Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS; International Society of Paediatric Oncology; United Kingdom Children's Cancer Study Group. Taylor RE, et al. Among authors: imeson j. J Clin Oncol. 2003 Apr 15;21(8):1581-91. doi: 10.1200/JCO.2003.05.116. J Clin Oncol. 2003. PMID: 12697884 Clinical Trial.
The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever P, Hale J, Bailey S, Oakhill A. Mann JR, et al. Among authors: imeson j. J Clin Oncol. 2000 Nov 15;18(22):3809-18. doi: 10.1200/JCO.2000.18.22.3809. J Clin Oncol. 2000. PMID: 11078494 Clinical Trial.
Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
Pritchard-Jones K, Kelsey A, Vujanic G, Imeson J, Hutton C, Mitchell C; United Kingdom Children's Cancer Study Group; Wilm's Tumor Working Group. Pritchard-Jones K, et al. Among authors: imeson j. J Clin Oncol. 2003 Sep 1;21(17):3269-75. doi: 10.1200/JCO.2003.01.062. J Clin Oncol. 2003. PMID: 12947062 Clinical Trial.
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
Grundy RG, Hutton C, Middleton H, Imeson J, Pritchard J, Kelsey A, Marsden HB, Vujanic GM, Taylor RE; United Kingdom Children's Cancer Study Group. Grundy RG, et al. Among authors: imeson j. Pediatr Blood Cancer. 2004 Apr;42(4):311-9. doi: 10.1002/pbc.10477. Pediatr Blood Cancer. 2004. PMID: 14966826 Clinical Trial.
UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group.
Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Phillips M, Sokal M, Gray E, McKeever P, Oakhill A. Mann JR, et al. Among authors: imeson j. Med Pediatr Oncol. 1998 Apr;30(4):217-27. doi: 10.1002/(sici)1096-911x(199804)30:4<217::aid-mpo3>3.0.co;2-j. Med Pediatr Oncol. 1998. PMID: 9473756 Review.
52 results